Earnings History Data for Sagimet Biosciences Inc. (SGMT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Sagimet Biosciences Inc.
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel therapeutics targeting dysfunctional metabolic pathways. Sagimet Biosciences Inc. is based in SAN MATEO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | SGMT | Sagimet Biosciences Inc. | 182.00 | -0.45 | -0.47 | 0.00 | Sagimet Biosciences GAAP EPS of -$0.45 [11/14/2024 3:19 PM] |
5.18 | -0.83 (-13.87%) |
6.00 | -0.02 (-0.33%) |
2.25 - 20.71 | 1,245,415 | 760,000 | 4,336 | ||
| 14-08-2024 | PM | SGMT | Sagimet Biosciences Inc. | 80.00 | -0.25 | -0.34 | 0.00 | 2.49 | -0.17 (-6.39%) |
0.0 | 0.0 (0.00%) |
2.13 - 20.71 | 460,566 | 230,000 | 0 | |||
|
|
||||||||||||||||||
| 15-05-2024 | PM | SGMT | Sagimet Biosciences Inc. | 135.00 | -0.23 | -0.41 | 0.00 | 4.65 | 0.27 (6.14%) |
4.48 | 0.10 (2.28%) |
2.13 - 20.71 | 347,680 | 480,000 | 4,634 | |||
|
|
||||||||||||||||||
| 13-11-2023 | PM | SGMT | Sagimet Biosciences Inc. | 60.00 | -0.35 | -1.02 | 0.00 | Sagimet Biosciences GAAP EPS of -$0.35, revenue of $2M [11/13/2023 2:33 PM] |
2.23 | -0.35 (-13.54%) |
0.0 | 0.0 (0.00%) |
2.13 - 18.33 | 160,426 | 80,000 | 0 | ||
| 21-08-2023 | AH | SGMT | Sagimet Biosciences Inc. | 281.00 | -35.80 | -0.49 | 0.00 | Sagimet Biosciences GAAP EPS of -$35.80 [8/21/2023 4:41 PM] |
10.63 | -1.68 (-13.65%) |
0.0 | 0.0 (0.00%) |
10.51 - 18.33 | 136,032 | 200,000 | 0 | ||